These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1271 related items for PubMed ID: 16390864

  • 41. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
    Cohick WS, Armstrong JD, Whitacre MD, Lucy MC, Harvey RW, Campbell RM.
    Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
    [Abstract] [Full Text] [Related]

  • 42. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N, Doi SQ, Shapiro JR.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [Abstract] [Full Text] [Related]

  • 43. The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs.
    Vinter-Jensen L, Juhl CO, Frystyk J, Dajani EZ, Oksbjerg N, Flyvbjerg A.
    J Endocrinol; 1996 Dec; 151(3):401-7. PubMed ID: 8994385
    [Abstract] [Full Text] [Related]

  • 44. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 45. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M, Blum WF, Muche R, Heinze E, Haug C, Mayer H, Teller W.
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [Abstract] [Full Text] [Related]

  • 46. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 47. Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme.
    Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2111-6. PubMed ID: 8964836
    [Abstract] [Full Text] [Related]

  • 48. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 49. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO.
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [Abstract] [Full Text] [Related]

  • 50. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V, Mattsson AF, Gaillard RC, Wilton P, Koltowska-Häggström M, Ranke MB.
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
    [Abstract] [Full Text] [Related]

  • 51. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
    de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
    [Abstract] [Full Text] [Related]

  • 52. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P, Bayón C, Méndez J, Gancedo PG, Grande C, Diez JJ.
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [Abstract] [Full Text] [Related]

  • 53. Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration.
    Mynarcik DC, Frost RA, Lang CH, DeCristofaro K, McNurlan MA, Garlick PJ, Steigbigel RT, Fuhrer J, Ahnn S, Gelato MC.
    J Acquir Immune Defic Syndr; 1999 Sep 01; 22(1):49-55. PubMed ID: 10534146
    [Abstract] [Full Text] [Related]

  • 54. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P, Brismar K, Rosenfeld RG, Hall K.
    J Clin Endocrinol Metab; 1994 Apr 01; 78(4):960-7. PubMed ID: 7512573
    [Abstract] [Full Text] [Related]

  • 55. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Kaprara A, Blakeman J, Vainas I, Mpousoulegas A, Williams CJ, Mantzoros C.
    Eur J Endocrinol; 2007 Feb 01; 156(2):187-94. PubMed ID: 17287408
    [Abstract] [Full Text] [Related]

  • 56. Circulating insulin-like growth factor I, insulin-like growth factor binding proteins, growth hormone, and resumption of estrus in postpartum cows subjected to dietary energy restriction.
    Roberts AJ, Nugent RA, Klindt J, Jenkins TG.
    J Anim Sci; 1997 Jul 01; 75(7):1909-17. PubMed ID: 9222849
    [Abstract] [Full Text] [Related]

  • 57. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
    Zhou X, Loke KY, Pillai CC, How HK, Yap HK, Lee KO.
    Eur J Endocrinol; 2001 Mar 01; 144(3):237-43. PubMed ID: 11248742
    [Abstract] [Full Text] [Related]

  • 58. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2290-300. PubMed ID: 15126555
    [Abstract] [Full Text] [Related]

  • 59. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C, Fatti L, Camboni MG, Porcu L, Danesi L, Delitala G, Cavagnini F.
    J Endocrinol Invest; 1996 Sep 01; 19(8):548-55. PubMed ID: 8905479
    [Abstract] [Full Text] [Related]

  • 60. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H.
    Kidney Int; 1999 Dec 01; 56(6):2076-84. PubMed ID: 10594783
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 64.